Skip to content
10-K

Annual Report

VitaNova Life Sciences Corporation VNOV

0001683168-24-005110

← back to feed
Filed
Jul 29, 2024 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding FY 2024 · Jul 29, 2024 25.01M sh
Shares Diluted FY 2024 · Apr 30, 2023 5.87M sh
Operating Cash Flow FY 2024 · Apr 30, 2023 −$18.38K
Current Liabilities FY 2024 · Apr 30, 2023 $67.94K
Total Liabilities FY 2024 · Apr 30, 2023 $67.94K
Current Assets FY 2024 · Apr 30, 2023 $8.73K
Total Assets FY 2024 · Apr 30, 2023 $8.73K
Eps Diluted FY 2024 · Apr 30, 2023 $0.00
Eps Basic FY 2024 · Apr 30, 2023 $0.00
Sga Expense FY 2024 · Apr 30, 2023 $62.23K
Net Income FY 2024 · Apr 30, 2023 −$24.23K
Operating Income FY 2024 · Apr 30, 2023 −$24.23K
Gross Profit FY 2024 · Apr 30, 2023 $38K
Cost Of Revenue FY 2024 · Apr 30, 2023 $0
Revenue FY 2024 · Apr 30, 2023 $38K
Stockholders Equity FY 2024 · Apr 30, 2022 −$34.99K